Sentinel Analytic Packages
Public
Source
2
2
3
3
# Sentinel Analytic Packages 4
4
5
5
#### Overview 6
6
A Sentinel analytic package is a standard folder structure containing detailed user-defined specifications, input files, SAS� macros, and SAS programs used to conduct Sentinel's routine querying analyses. A package allows the user to select the cohort(s) of interest in order to examine their health profile and outcomes. 7
7
8
8
Sentinel's analytic request packages are intended to run on data formatted in accordance with the [Sentinel Common Data Model (SCDM)](https://dev.sentinelsystem.org/projects/QA/repos/sentinel_common_data_model/browse). Note that data must be in SAS datasets to use these analytic programs. 9
9
10
10
##### Analytic Request Packages Available for Download 11
11
|Request ID|Summary|12
-
|-----|-----|12
+
|cder_mpl2p_wp012|Intentional Self-Harm and Hospitalized Depression Following Sertraline Use: A Propensity Score Matched Analysis|13
+
|cder_mpl2r_wp012|Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis|13
14
|cder_mpl2r_wp012|Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis|14
15
|cder_mpl2p_wp021|Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis, Part 2|15
16
|cder_mpl2r_wp016|Angioedema following Sacubitril/Valsartan Use in Patients with Heart Failure: A Propensity Score Analysis, Part 1|16
17
|cder_mpl2r_wp014|Cutaneous Small-Vessel Vasculitis following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis|17
18
|cder_mpl2p_wp025|Thromboembolic Stroke, Intracranial Hemorrhage, Gastrointestinal Bleeding, and Major Extracranial Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients with Atrial Fibrillation: A Propensity Score Matched Analysis|18
19
|cder_mpl2r_wp015|A New Propensity Score Matched Analysis Tool for Pregnancy: Replicating A Study of Oral Clefts following Topiramate Use during the First Trimester of Pregnancy|19
20
|cder_mpl2p_wp015|Factors Related to the Assignment of Sodium Glucose Cotransporter-2 Inhibitors (SGLT-2i) versus Dipeptidyl Peptidase-4 Inhibitors (DPP-4i)|20
21
|cder_mpl2p_wp017|Stroke, Intracranial Hemorrhage, and Bleeding following Dabigatran, Rivaroxaban, and Apixaban Use in Patients Aged 65 or Older: A Propensity Score Matched Analysis|21
22
|cder_mpl2p_wp018|Severe Uterine Bleed following Novel Oral Anticoagulants Use: A Propensity Score Stratified Analysis (an update to cder_mpl2p_wp007)|22
23
|cder_mpl1r_wp176|Diminished Visual Acuity and Nasal Septal Perforation following Mometasone Sinus Implant Use in Patients with Nasal Polyposis: A Descriptive Analysis (an update to cder_mpl1r_wp157), Part 2|